262 related articles for article (PubMed ID: 15840669)
1. Angiotensin II stimulates alpha3(IV) collagen production in mouse podocytes via TGF-beta and VEGF signalling: implications for diabetic glomerulopathy.
Chen S; Lee JS; Iglesias-de la Cruz MC; Wang A; Izquierdo-Lahuerta A; Gandhi NK; Danesh FR; Wolf G; Ziyadeh FN
Nephrol Dial Transplant; 2005 Jul; 20(7):1320-8. PubMed ID: 15840669
[TBL] [Abstract][Full Text] [Related]
2. Effects of high glucose and TGF-beta1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes.
Iglesias-de la Cruz MC; Ziyadeh FN; Isono M; Kouahou M; Han DC; Kalluri R; Mundel P; Chen S
Kidney Int; 2002 Sep; 62(3):901-13. PubMed ID: 12164872
[TBL] [Abstract][Full Text] [Related]
3. Podocyte-derived vascular endothelial growth factor mediates the stimulation of alpha3(IV) collagen production by transforming growth factor-beta1 in mouse podocytes.
Chen S; Kasama Y; Lee JS; Jim B; Marin M; Ziyadeh FN
Diabetes; 2004 Nov; 53(11):2939-49. PubMed ID: 15504975
[TBL] [Abstract][Full Text] [Related]
4. Parathyroid hormone-related protein induces hypertrophy in podocytes via TGF-beta(1) and p27(Kip1): implications for diabetic nephropathy.
Romero M; Ortega A; Izquierdo A; López-Luna P; Bosch RJ
Nephrol Dial Transplant; 2010 Aug; 25(8):2447-57. PubMed ID: 20200004
[TBL] [Abstract][Full Text] [Related]
5. Influence of C-peptide on early glomerular changes in diabetic mice.
Maezawa Y; Yokote K; Sonezaki K; Fujimoto M; Kobayashi K; Kawamura H; Tokuyama T; Takemoto M; Ueda S; Kuwaki T; Mori S; Wahren J; Saito Y
Diabetes Metab Res Rev; 2006; 22(4):313-22. PubMed ID: 16389646
[TBL] [Abstract][Full Text] [Related]
6. [Transforming growth factor-beta1 stimulates matrix metalloproteinase-9 production through ERK activation pathway and upregulation of Ets-1 protein].
Huang HC; Liu SY; Liang Y; Liu Y; Li JZ; Wang HY
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):328-31. PubMed ID: 15854510
[TBL] [Abstract][Full Text] [Related]
7. Secretion of collagen type IV by human renal fibroblasts is increased by high glucose via a TGF-beta-independent pathway.
Lam S; van der Geest RN; Verhagen NA; Daha MR; van Kooten C
Nephrol Dial Transplant; 2004 Jul; 19(7):1694-701. PubMed ID: 15150349
[TBL] [Abstract][Full Text] [Related]
8. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy.
Han SY; Jee YH; Han KH; Kang YS; Kim HK; Han JY; Kim YS; Cha DR
Nephrol Dial Transplant; 2006 Sep; 21(9):2406-16. PubMed ID: 16728425
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II, transforming growth factor-beta1 and repair in the infarcted heart.
Sun Y; Zhang JQ; Zhang J; Ramires FJ
J Mol Cell Cardiol; 1998 Aug; 30(8):1559-69. PubMed ID: 9737942
[TBL] [Abstract][Full Text] [Related]
10. Antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor blockers in pancreatic ductal adenocarcinoma.
Arafat HA; Gong Q; Chipitsyna G; Rizvi A; Saa CT; Yeo CJ
J Am Coll Surg; 2007 May; 204(5):996-1005; discussion 1005-6. PubMed ID: 17481528
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity.
Fujiwara M; Muragaki Y; Ooshima A
Arch Dermatol Res; 2005 Oct; 297(4):161-9. PubMed ID: 16184401
[TBL] [Abstract][Full Text] [Related]
12. Crim1KST264/KST264 mice implicate Crim1 in the regulation of vascular endothelial growth factor-A activity during glomerular vascular development.
Wilkinson L; Gilbert T; Kinna G; Ruta LA; Pennisi D; Kett M; Little MH
J Am Soc Nephrol; 2007 Jun; 18(6):1697-708. PubMed ID: 17460146
[TBL] [Abstract][Full Text] [Related]
13. Inhibiting albumin glycation attenuates dysregulation of VEGFR-1 and collagen IV subchain production and the development of renal insufficiency.
Cohen MP; Lautenslager GT; Hud E; Shea E; Wang A; Chen S; Shearman CW
Am J Physiol Renal Physiol; 2007 Feb; 292(2):F789-95. PubMed ID: 17018845
[TBL] [Abstract][Full Text] [Related]
14. High glucose and angiotensin II increase beta1 integrin and integrin-linked kinase synthesis in cultured mouse podocytes.
Han SY; Kang YS; Jee YH; Han KH; Cha DR; Kang SW; Han DS
Cell Tissue Res; 2006 Feb; 323(2):321-32. PubMed ID: 16189717
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin type 1 receptor blocker restores podocyte potential to promote glomerular endothelial cell growth.
Liang XB; Ma LJ; Naito T; Wang Y; Madaio M; Zent R; Pozzi A; Fogo AB
J Am Soc Nephrol; 2006 Jul; 17(7):1886-95. PubMed ID: 16790514
[TBL] [Abstract][Full Text] [Related]
16. VEGF induces proliferation, migration, and TGF-beta1 expression in mouse glomerular endothelial cells via mitogen-activated protein kinase and phosphatidylinositol 3-kinase.
Li ZD; Bork JP; Krueger B; Patsenker E; Schulze-Krebs A; Hahn EG; Schuppan D
Biochem Biophys Res Commun; 2005 Sep; 334(4):1049-60. PubMed ID: 16039615
[TBL] [Abstract][Full Text] [Related]
17. MEK mediates the novel cross talk between TNFR2 and TGF-EGFR in enhancing vascular endothelial growth factor (VEGF) secretion from human mesenchymal stem cells.
Wang Y; Wang M; Abarbanell AM; Weil BR; Herrmann JL; Tan J; Novotny NM; Coffey AC; Meldrum DR
Surgery; 2009 Aug; 146(2):198-205. PubMed ID: 19628074
[TBL] [Abstract][Full Text] [Related]
18. mRNA expression of glomerular basement membrane proteins and TGF-beta1 in human membranous nephropathy.
Kim TS; Kim JY; Hong HK; Lee HS
J Pathol; 1999 Nov; 189(3):425-30. PubMed ID: 10547606
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II increases collagen I expression via transforming growth factor-beta1 and extracellular signal-regulated kinase in cardiac fibroblasts.
Gao X; He X; Luo B; Peng L; Lin J; Zuo Z
Eur J Pharmacol; 2009 Mar; 606(1-3):115-20. PubMed ID: 19374881
[TBL] [Abstract][Full Text] [Related]
20. Glucagon like peptide-2 induces intestinal restitution through VEGF release from subepithelial myofibroblasts.
Bulut K; Pennartz C; Felderbauer P; Meier JJ; Banasch M; Bulut D; Schmitz F; Schmidt WE; Hoffmann P
Eur J Pharmacol; 2008 Jan; 578(2-3):279-85. PubMed ID: 17920582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
